Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 5
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Recent Advances in the Immunoassays Based on Nanozymes.
Zhou L, Liu Y, Lu Y, Zhou P, Lu L, Lv H, Hai X. Zhou L, et al. Among authors: zhou p. Biosensors (Basel). 2022 Dec 2;12(12):1119. doi: 10.3390/bios12121119. Biosensors (Basel). 2022. PMID: 36551085 Free PMC article. Review.
Retraction Note: Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.
Zhu GF, Xu YW, Li J, Niu HL, Ma WX, Xu J, Zhou PR, Liu X, Ye DL, Liu XR, Yan T, Zhai WK, Xu ZJ, Liu C, Wang L, Wang H, Luo JM, Liu L, Li XQ, Guo S, Jiang HP, Shen P, Lin HK, Yu DH, Ding YQ, Zhang QL. Zhu GF, et al. Nat Commun. 2023 Sep 18;14(1):5772. doi: 10.1038/s41467-023-41612-z. Nat Commun. 2023. PMID: 37723148 Free PMC article. No abstract available.
Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.
Zhu GF, Xu YW, Li J, Niu HL, Ma WX, Xu J, Zhou PR, Liu X, Ye DL, Liu XR, Yan T, Zhai WK, Xu ZJ, Liu C, Wang L, Wang H, Luo JM, Liu L, Li XQ, Guo S, Jiang HP, Shen P, Lin HK, Yu DH, Ding YQ, Zhang QL. Zhu GF, et al. Nat Commun. 2019 Jan 10;10(1):112. doi: 10.1038/s41467-018-07998-x. Nat Commun. 2019. PMID: 30631060 Free PMC article. Retracted.
VDR Signaling via the Enzyme NAT2 Inhibits Colorectal Cancer Progression.
Zhu C, Wang Z, Cai J, Pan C, Lin S, Zhang Y, Chen Y, Leng M, He C, Zhou P, Wu C, Fang Y, Li Q, Li A, Liu S, Lai Q. Zhu C, et al. Among authors: zhou p. Front Pharmacol. 2021 Nov 16;12:727704. doi: 10.3389/fphar.2021.727704. eCollection 2021. Front Pharmacol. 2021. PMID: 34867333 Free PMC article.
14 results